EGA structure
|
Common Name | EGA | ||
|---|---|---|---|---|
| CAS Number | 415687-81-9 | Molecular Weight | 346.222 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C16H16BrN3O | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07, GHS09 |
Signal Word | Warning | |
Use of EGAEGA is a selective inhibitor of endosomol trafficking pathways exploited by multiple toxins and virus[1]. |
| Name | (2E)-2-(4-Bromobenzylidene)-N-(2,6-dimethylphenyl)hydrazinecarboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | EGA is a selective inhibitor of endosomol trafficking pathways exploited by multiple toxins and virus[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C16H16BrN3O |
| Molecular Weight | 346.222 |
| Exact Mass | 345.047668 |
| LogP | 5.38 |
| Index of Refraction | 1.609 |
| Symbol |
GHS07, GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335-H410 |
| Precautionary Statements | P261-P273-P305 + P351 + P338-P501 |
| RIDADR | UN 3077 9 / PGIII |
| (2E)-2-(4-Bromobenzylidene)-N-(2,6-dimethylphenyl)hydrazinecarboxamide |
| Hydrazinecarboxamide, 2-[(4-bromophenyl)methylene]-N-(2,6-dimethylphenyl)-, (2E)- |
| MFCD28118904 |